Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Rani Therapeutics, a clinical-stage biotherapeutics company, announced that CEO Talat Imran will present at the 22^nd Annual Needham Virtual Healthcare Conference on April 18, 2023, at 12:45 p.m. PT / 3:45 p.m. ET. The presentation will focus on Rani's innovative RaniPill capsule technology, designed to facilitate the oral delivery of biologics and drugs, potentially replacing subcutaneous and intravenous methods. Interested individuals can access the live webcast via Rani's Investor Relations page, with replays available for approximately 90 days post-event. Rani Therapeutics is committed to advancing oral drug delivery technologies and has successfully completed multiple studies to assess the safety and efficacy of its RaniPill platform.

SAN JOSE, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the company’s Chief Executive Officer, Talat Imran, will present at the 22^nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 12:45 p.m. PT / 3:45 p.m. ET.

Interested parties can access the live webcasts for these conferences from the Investor Relations section of the company's website at www.ranitherapeutics.com. The webcast replays will be available after the conclusion of the respective presentations for approximately 90 days.

Rani Therapeutics

Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill capsule technology. For more information, visit ranitherapeutics.com.

Investor Contact:

investors@ranitherapeutics.com 

Media Contact:

media@ranitherapeutics.com 

FAQ

When will Rani Therapeutics CEO Talat Imran present at the Needham Conference?

Talat Imran will present on April 18, 2023, at 12:45 p.m. PT / 3:45 p.m. ET.

What is the focus of Rani Therapeutics' presentation at the conference?

The presentation will focus on Rani's RaniPill capsule technology for oral delivery of biologics and drugs.

How can I access the Rani Therapeutics conference presentation?

The live webcast can be accessed from the Investor Relations section of Rani Therapeutics' website.

Will there be a replay of Rani Therapeutics' presentation?

Yes, the replay will be available for approximately 90 days after the presentation.

What is the significance of the RaniPill capsule technology?

It aims to replace subcutaneous injections and intravenous infusions with an oral dosing method.